Every serving. No expiration date. Page 3 of 4.
In a 10-person safety trial, an experimental optogenetic treatment produced clinically meaningful light-sensitivity gains in six participants. It did not restore normal sight.
Human lung organoids retained resident T cells, recognized SARS-CoV-2 and responded more strongly after a simulated booster.
Functional testing on skin cells helped close difficult mitochondrial-disease diagnoses across samples from more than 30 medical centres.
The pollinators carried a precise biological treatment to as many as 88% of flowers.
Panels make power now. Molten salt is designed to hold heat for later.
At 90,000–120,000 miles, EVs were about 25% less likely to fail an MOT.
The fabric let light, rain and air through — while keeping insect mouths out.
Two fins. One layer of living muscle. A light to follow.
Old batteries, panels and blades are starting to feed the next buildout.
The clean-power buildout turned into an energy-security shield when global gas prices spiked.
Three remote counseling sessions and a phone tool helped young people make safer decisions in a rigorous trial.
Four weeks of at-home magnetic-field sessions produced encouraging early signals for long-COVID cognitive impairment.
A small trial suggests the first medication for lymphedema may be getting closer.
A Phase 3 trial turned the walls of a surgical cavity into the radiation treatment.
A small scheduling change produced a surprisingly large clinical difference.
The first global political declaration on sea-level rise says an island state does not stop being a country because rising water makes its land uninhabitable.
A painless test using urine and a vaginal swab showed it could accurately rule out womb cancer for most women with postmenopausal bleeding.
The final turbine is installed at Revolution Wind, a 704-megawatt offshore project built to serve Rhode Island and Connecticut.
HALO Trust has concluded humanitarian mine clearance in Kosovo, 27 years after the war left fields, roads and villages contaminated.
A Cambridge-led study gave nicotinamide riboside to eight people with mitochondrial DNA disease. It was well tolerated and showed early signs of working.
Europe's largest economy published a sector-by-sector plan to leave coal, oil and gas behind, only the third country to do so.
Book Bunk and Nairobi City County restored Eastlands and Kaloleni public libraries as free civic hubs. Book Bunk reports patronage up more than 240%.
In a mouse model of multiple sclerosis, the experimental drug K-9 restored function after paralysis and vision loss had already set in. It has not been tested in people with MS.
In the TESEO trial, 450 adults received different benznidazole regimens. The 30-day, once-daily option matched the standard 60-day course in the trial and caused fewer side effects.